Isomerization of cyclic ethers having a carbonyl functional group: new entries into different heterocyclic compounds
摘要:
Oxiranes (epoxides) and oxetanes having a carbonyl functional group are chemoselectively isomerized to different heterocyclic compounds via Lewis acid-promoted 1,6- and 1,7-intramolecular nucleophilic attacks of the carbonyl oxygen on the electron-deficient carbon neighboring the oxonium oxygen: for example, cyclic imides to bicyclic acetals, esters to bicyclic orthoesters, sec-amides to 4,5-dihydrooxazole or 5,6-dihydro-4H-1,3-oxazines, and tert-amides to bicyclic acetals or azetidines. The intramolecular attack of a 1,5-positioned carbonyl oxygen predominantly results in a propagating-end isomerization polymerization. On the other hand, cyclic ethers having a 1,8- or farther positioned carbonyl group undergo conventional ring-opening polymerization. A tetrahydrofuran (oxolane) ring does not open, even with a 1,6-positioned carbonyl group. (C) 2002 Elsevier Science Ltd. All rights reserved.
Isomerization of cyclic ethers having a carbonyl functional group: new entries into different heterocyclic compounds
摘要:
Oxiranes (epoxides) and oxetanes having a carbonyl functional group are chemoselectively isomerized to different heterocyclic compounds via Lewis acid-promoted 1,6- and 1,7-intramolecular nucleophilic attacks of the carbonyl oxygen on the electron-deficient carbon neighboring the oxonium oxygen: for example, cyclic imides to bicyclic acetals, esters to bicyclic orthoesters, sec-amides to 4,5-dihydrooxazole or 5,6-dihydro-4H-1,3-oxazines, and tert-amides to bicyclic acetals or azetidines. The intramolecular attack of a 1,5-positioned carbonyl oxygen predominantly results in a propagating-end isomerization polymerization. On the other hand, cyclic ethers having a 1,8- or farther positioned carbonyl group undergo conventional ring-opening polymerization. A tetrahydrofuran (oxolane) ring does not open, even with a 1,6-positioned carbonyl group. (C) 2002 Elsevier Science Ltd. All rights reserved.
Reductive Alkylation of Amines with Carboxylic Ortho Esters
作者:Renat Kadyrov、Konrad Moebus
DOI:10.1002/adsc.202000510
日期:2020.8.19
carboxylic ortho esters could be used as an alkylating agent in the reductivealkylation of amines. A variety of amines, including amino acid esters, were alkylated affording mono‐alkylated products with high selectivity in practical to high yields using standard heterogeneous catalysts. By applying acyclic ortho esters alkylation was completed at room temperature.
[EN] FLUORINATED ACRYLATES AS ADDITIVES FOR Li-ION BATTERY ELECTROLYTES<br/>[FR] ACRYLATES FLUORÉS UTILISÉS EN TANT QU'ADDITIFS POUR DES ELECTROLYTES DE BATTERIES LITHIUM-ION
申请人:BASF SE
公开号:WO2017050609A1
公开(公告)日:2017-03-30
A compound of formula (I) for use in electrolyte compositions for electrochemical cells.
[EN] TRIFUNCTIONAL ADDITIVES FOR ELECTROLYTE COMPOSITION FOR LITHIUM BATTERIES<br/>[FR] ADDITIFS TRIFONCTIONNELS POUR COMPOSITION ÉLECTROLYTIQUE POUR BATTERIES AU LITHIUM
申请人:BASF SE
公开号:WO2018134251A1
公开(公告)日:2018-07-26
An electrolyte composition containing (i) at least one aprotic organic solvent; (ii) at least one conducting salt; (iii) at least one compound of formula (I); and (iv) optionally one or more additives.
[EN] USE OF REACTIVE IONIC LIQUIDS AS ADDITIVES FOR ELECTROLYTES IN SECONDARY LITHIUM ION BATTERIES<br/>[FR] UTILISATION DE LIQUIDES IONIQUES RÉACTIFS COMME ADDITIFS POUR ÉLECTROLYTES DANS DES BATTERIES LITHIUM-ION SECONDAIRES
申请人:BASF SE
公开号:WO2015150390A1
公开(公告)日:2015-10-08
The present invention relates to compounds of formula (I) wherein X is N or P; -SO3- is -O-S(O)2 -or -S(O)2-O-; and n and R1 to R5 are defined below, and to their use as additives for electrolyte compositions, in particular in electrolyte compositions for lithium batteries.
Compositions Comprising a Polymeric Reagent and a Pharmacologically Active Agent
申请人:NEKTAR THERAPEUTICS
公开号:US20150328331A1
公开(公告)日:2015-11-19
Pharmaceutical compositions of conjugates are provided. The conjugates can be prepared by (among other ways) conjugating a pharmacologically active agent with a polymeric reagent that has a particular arrangement of atoms. Related methods, preparations, and so forth are also provided.